Bristol Myers Squibb Co (BMY) Price Targets From Analysts
Use the tables below to see what analysts covering Bristol Myers Squibb Co think about its future price and what recommendations they have for investors and traders.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 17 | $90 | $62 | $75.37 | $66.47 | 13.39% |
The Trend in the Analyst Price Target
BMY's average price target has moved up $0.24 over the prior 85 days.
Over the past 13 months, BMY's average upside potential has been 19.62%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-06-13 | 17 | 90 | 62 | 75.37 | 67.34 | 11.92% |
| 2021-06-05 | 17 | 90 | 62 | 75.37 | 64.94 | 16.06% |
| 2021-05-22 | 17 | 90 | 62 | 75.31 | 67.05 | 12.32% |
| 2021-05-15 | 16 | 90 | 62 | 75.63 | 64.88 | 16.57% |
| 2021-05-08 | 16 | 89 | 62 | 75.44 | 64.44 | 17.07% |
| 2021-04-25 | 16 | 87 | 66 | 76.00 | 66.01 | 15.13% |
| 2021-04-17 | 16 | 87 | 66 | 76.00 | 65.46 | 16.1% |
| 2021-04-10 | 16 | 86 | 66 | 75.38 | 62.61 | 20.4% |
| 2021-04-03 | 16 | 86 | 66 | 75.38 | 62.93 | 19.78% |
| 2021-03-20 | 16 | 86 | 66 | 75.13 | 62.70 | 19.82% |
| 2021-03-13 | 16 | 86 | 66 | 75.13 | 60.64 | 23.9% |
| 2021-03-06 | 15 | 86 | 66 | 75.53 | 60.43 | 24.99% |
| 2021-02-27 | 16 | 86 | 66 | 75.13 | 61.33 | 22.5% |
| 2021-02-20 | 16 | 86 | 66 | 75.13 | 60.60 | 23.98% |
| 2021-02-13 | 16 | 86 | 66 | 74.88 | 59.99 | 24.82% |
| 2021-02-06 | 16 | 86 | 66 | 74.75 | 60.92 | 22.7% |
| 2021-01-30 | 16 | 88 | 65 | 74.94 | 61.43 | 21.99% |
| 2021-01-23 | 17 | 88 | 65 | 74.88 | 64.56 | 15.99% |
| 2021-01-16 | 17 | 88 | 64 | 74.76 | 66.54 | 12.35% |
| 2021-01-09 | 17 | 88 | 64 | 74.76 | 62.49 | 19.64% |
| 2021-01-02 | 17 | 88 | 64 | 74.76 | 62.03 | 20.52% |
| 2020-12-26 | 17 | 88 | 64 | 74.76 | 61.15 | 22.26% |
| 2020-12-19 | 17 | 88 | 64 | 74.59 | 63.12 | 18.17% |
| 2020-12-09 | 17 | 88 | 64 | 74.29 | 60.92 | 21.95% |
| 2020-12-07 | 17 | 88 | 64 | 74.29 | 61.20 | 21.39% |
| 2020-11-19 | 16 | 88 | 64 | 74.06 | 62.09 | 19.28% |
| 2020-11-06 | 16 | 88 | 64 | 73.12 | 63.80 | 14.61% |
| 2020-10-27 | 15 | 88 | 64 | 73.07 | 58.74 | 24.4% |
| 2020-09-25 | 13 | 87 | 64 | 73.54 | 59.49 | 23.62% |
| 2020-09-24 | 12 | 87 | 64 | 73.58 | 58.25 | 26.32% |
| 2020-09-09 | 12 | 85 | 64 | 73.17 | 59.08 | 23.85% |
| 2020-08-28 | 12 | 85 | 64 | 73.17 | 62.37 | 17.32% |
| 2020-08-20 | 11 | 85 | 64 | 73.18 | 62.22 | 17.61% |
| 2020-08-13 | 12 | 85 | 64 | 73.17 | 63.24 | 15.7% |
| 2020-08-06 | 12 | 83 | 62 | 72.08 | 61.33 | 17.53% |
| 2020-07-21 | 11 | 81 | 62 | 71.36 | 59.80 | 19.33% |
| 2020-06-26 | 11 | 81 | 62 | 71.36 | 57.54 | 24.02% |
| 2020-06-16 | 11 | 81 | 62 | 71.91 | NA | NA% |
| 2020-06-02 | 11 | 81 | 62 | 71.91 | NA | NA% |
BMY Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.48 | 7 | 7 | 6 | 0 | 0 | 20 |
The Trend in the Broker Recommendations
Over the past 26 weeks, BMY's average broker recommendation rating worsened by 0.05.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BMY as an investment opportunity.
- Bristol Myers Squibb Co's number of analysts covering the stock is higher than 89.62% of all US stocks.
- Bristol Myers Squibb Co's average analyst price target is higher than 88.06% of Pharmaceutical Products stocks.
- BMY has a higher upside potential (average analyst target price relative to current price) than 13.53% of Pharmaceutical Products stocks.
- Bristol Myers Squibb Co's variance in analysts' estimates is less than 36.31% of all US stocks.
Stocks similar to Bristol Myers Squibb Co in the Pharmaceutical Products industry regarding analyst recommendations and price targets are BMRN, FATE and JNJ.
What is the outlook for BMY? Use POWR Ratings for clearer insight into price direction.